Advertisement

Topics

Prosensa Holding N.V. Company Profile

22:11 EDT 23rd September 2018 | BioPortfolio

Prosensa is a Dutch biotechnology company engaged in the discovery and development of RNA-modulating therapeutics for the treatment of genetic disorders. Its primary focus is on rare neuromuscular and neurodegenerative disorders with a large unmet medical need, including Duchenne muscular dystrophy, myotonic dystrophy and Huntington’s disease.


News Articles [301 Associated News Articles listed on BioPortfolio]

Luc Dochez on why Prosensa’s exon skipping therapy is personalised medicine in its ultimate form for Duchenne’s

In this episode of PharmaTelevision News Review, Fintan Walton talks to Luc Dochez, CBO and Senior VP BD, Prosensa.

Dedicated to enabling long term patient access to drisapersen as novel treatment for DMD: Hans Schikan, CEO Prosensa

In this interview, filmed in London, Fintan Walton talks to Hans Schikan, CEO of Prosensa. Prosensa is a biotechnology company focused on the discovery, development and commercialization of RNA-modula...

Prosensa: Luc Dochez. Developing therapies for neuromuscular diseases

In this episode of PharmaTelevision News Review, filmed at BioEurope 2012 in Hamburg, Germany, Fintan Walton talks to Luc Dochez the CBO and Senior VP Business Development at Prosensa

Prosensa: Luc Dochez. Using their RNA modulating platform to help patients with Duchenne's, Myotonic Dystrophy and Huntington’s.

In this episode of PharmaTelevision News Review, Fintan Walton talks to Luc Dochez, Chief Business Officer and SVP Business Development of Prosensa.

Life science-veteran ny vd för UU holding

Gunilla Lundmark tillträder som ny vd för Uppsala universitets holdingbolag, UU holding.

DGAP-News: Dermapharm Holding SE: Dermapharm setzt 2017 profitables Wachstum fort (deutsch)

Dermapharm Holding SE: Dermapharm setzt 2017 profitables Wachstum fort DGAP-News: Dermapharm Holding SE / Schlagwort(e): Vorläufiges Ergebnis Dermapharm Holding SE: Dermapharm setzt 2017 profitabl...

Itaú Unibanco Holding S.A. Pagamento de Dividendos e Juros sobre o Capital Próprio Complementares

SÃO PAULO, 30 de julho de 2018 /PRNewswire/ -- ITAÚ UNIBANCO HOLDING S.A. ("Companhia") (NYSE: ITUB) comunica aos seus acionistas que o Conselho de Administração, Read more...

Itaú Unibanco Holding S.A. Announcement to the Market - BRGAAP - Results for the 2nd Quarter ...

SÃO PAULO, July 30, 2018 /PRNewswire/ -- Itaú Unibanco Holding S.A. ("Company") (NYSE: ITUB) announces to its shareholders and the market at large that the Read more...

PubMed Articles [74 Associated PubMed Articles listed on BioPortfolio]

Disclosure and holding back: Communication, psychological adjustment, and marital satisfaction among couples coping with osteoarthritis.

This study examined two types of illness-related communication (disclosure and holding back) and their associations with psychological adjustment and marital satisfaction in patients with knee osteoar...

Evaluation of Skeletal and Dental Effects of Lower Lingual Arches.

A lower lingual arch is usually recommended as a holding device to maintain arch length and to prevent mesial migration of the mandibular first molars. Despite its widespread use, comparatively little...

Effects of Calcination Holding Time on Properties of Wide Band Gap Willemite Semiconductor Nanoparticles by the Polymer Thermal Treatment Method.

Willemite is a wide band gap semiconductor used in modern day technology for optoelectronics application. In this study, a new simple technique with less energy consumption is proposed. Willemite nano...

Motor experience with a sport-specific implement affects motor imagery.

The present study tested whether sport-specific implements facilitate motor imagery, whereas nonspecific implements disrupt motor imagery. We asked a group of basketball players (experts) and a group ...

Fully Soft 3D-Printed Electroactive Fluidic Valve for Soft Hydraulic Robots.

Soft robots are designed to utilize their compliance and contortionistic abilities to both interact safely with their environment and move through it in ways a rigid robot cannot. To more completely a...

Clinical Trials [83 Associated Clinical Trials listed on BioPortfolio]

Energy Cost for Holding a MedGem® Indirect Calorimeter

The goal of this clinical protocol is to perform a randomized crossover study to determine the energy cost of holding the MedGem® device above a person's normal resting metabolic rate (RM...

Kangaroo Holding Effects on Breast Milk

Kangaroo holding is a skin-to-skin method of holding a baby. Many research studies have investigated the maternal and infant benefits associated with kangaroo holding. The purpose of thi...

Kangaroo Holding and Maternal Stress

The primary objective is to determine if kangaroo holding in the first week after birth influences the stress levels of mothers who have delivered their infants prematurely and who require...

Holding, Stress and Bonding During Therapeutic Hypothermia Dyads During Therapeutic Hypothermia

Ten infants undergoing therapeutic hypothermia for hypoxic-ischemic encephalopathy will be enrolled in a new protocol that will allow mothers to hold their infants during the hypothermia t...

The Holding Area LINQ (Reveal LINQ Insertable Cardiac Monitor) Trial is a Prospective, Non-randomized, Single Center Post-market Clinical Trial

The Holding Area LINQ Trial is a clinical trial designed to compare the benefits in conducting impant procedures in the holding area of a hospital operating room vs cardiac catheterization...

Companies [268 Associated Companies listed on BioPortfolio]

Prosensa Holding N.V.

Prosensa is a Dutch biotechnology company engaged in the discovery and development of RNA-modulating therapeutics for the treatment of genetic disorders. Its primary focus is on r...

Prosensa

Prosensa is an innovative Dutch biopharmaceutical company focused on the discovery, development and commercialization of RNA modulating therapeutics correcting gene expression in ...

Aeroflex Holding Corp.

Aeroflex Holding Corp. is the holding company for Aeroflex Incorporated, a leading global provider of microelectronic components and test and measurement equipment used by compani...

IMIX Holding AB

IMIX Holding AB, based in Stockholm, is a newly created holding company for the IMIX group. The group is active within the field of digital radiology and consists of sales offices...

GlaxoSmithKline & Prosensa

GlaxoSmithKline – one of the world’s leading research-based pharmaceutical and healthcare companies – is committed to improving the quality of human life by enablin...

More Information about "Prosensa Holding N.V." on BioPortfolio

We have published hundreds of Prosensa Holding N.V. news stories on BioPortfolio along with dozens of Prosensa Holding N.V. Clinical Trials and PubMed Articles about Prosensa Holding N.V. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Prosensa Holding N.V. Companies in our database. You can also find out about relevant Prosensa Holding N.V. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Muscular Dystrophy
Muscular dystrophy is a group of degenerative inherited disorders causing muscle weakness and loss of muscle tissue. The different types are Becker muscular dystrophy, Duchenne muscular dystrophy, Emery-Dreifuss muscular dystrophy, Facioscapulohumeral mu...


Corporate Database Quicklinks



Searches Linking to this Company Record